Evidence map›Paper›PMID 36458222›Full record

ArticleIndian journal of microbiology2022

Construction of A375·S2 Melanoma Cell Line with High Sensibility to IL-1 by Overexpressing IL-1 Receptor.

Yong-Fei Zhou, Wei-Xiao Wang, Jiao-Jiao Nie, Dan-Ying Zhao, Lu Yu, Jun-Liang Chang, Jing-Hui Liu, Yu-Feng Cao

Open access · greenAbstract read
In one paragraph

Article in Indian journal of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yong-Fei Zhou *Changchun Institute of Biological Products Co. Ltd., Changchun, 130012 People's Republic of China.
Wei-Xiao Wang *Changchun Institute of Biological Products Co. Ltd., Changchun, 130012 People's Republic of China.
Jiao-Jiao NieSchool of Life Sciences, Jilin University, Changchun, 130012 People's Republic of China.
Dan-Ying ZhaoChangchun Institute of Biological Products Co. Ltd., Changchun, 130012 People's Republic of China.
Lu YuChangchun Institute of Biological Products Co. Ltd., Changchun, 130012 People's Republic of China.
Jun-Liang ChangChangchun Institute of Biological Products Co. Ltd., Changchun, 130012 People's Republic of China.
Jing-Hui LiuChangchun Institute of Biological Products Co. Ltd., Changchun, 130012 People's Republic of China.
Yu-Feng CaoChangchun Institute of Biological Products Co. Ltd., Changchun, 130012 People's Republic of China.
Changchun Institute of Biological Products · CNJilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We described an operation that co-overexpress interleukin receptor 1 (IL-1R1) and its co-receptor (IL-1R1AcP) genes in wild-type A375·S2 cells in order to increase their sensibility to IL-1. Firstly, laser scanning confocal microscope observed that IL-1R1 could be expressed on the surface of A375·S2 cells. qPCR was performed to estimate the ratio of two genes and result showed the ratio was almost 4.57:1. Then two genes were linked to vectors and co-transfected into A375·S2 cells. qPCR and Western blotting showed the protein content improved markedly. Finally, MTS assay was executed and the sensitivity of A375·S2 cells that co-transfected receptors to IL-1β increased significantly. Another MTS assay showed the cell activity variation changed significantly ( Supplementary Information: The online version contains supplementary material available at 10.1007/s12088-022-01027-8.

Indexed as

IL-1R1IL-1RaIL-1RAcPMTSRA

Identifiers

PMID36458222
PMCPMC9705671
OpenAlexW4292457845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.